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a b s t r a c t
The primitive endoderm (PE) and epiblast (EPI) are two lineages derived from the inner cell mass (ICM)
of the E3.5 blastocyst. Although it has been shown that FGF signaling is necessary and sufﬁcient for PE
speciﬁcation in the ICM, it is unknown what mechanisms control the PE/EPI proportion in the embryo.
Because modulation of FGF signaling alone is sufﬁcient to convert all ICM cells to either PE or EPI, a
model has been proposed in which the amount of FGF in the embryo controls the PE/EPI proportion. To
test this model, we reduced the amount of FGF4, the major FGF in the preimplantation embryo, using
various genotypes of Fgf4mutants. We observed a maternal contribution of Fgf4 in PE speciﬁcation, but it
was dispensable for development. In addition, upon treatment of Fgf4 mutant embryos with exogenous
FGF4, we observed a progressive increase of PE proportions in an FGF4 dose dependent manner,
regardless of embryo genotype. We conclude that the amount of FGF4 is limited and regulates PE/EPI
proportions in the mouse embryo.
& 2013 The Authors. Published by Elsevier Inc.
Introduction
The primitive endoderm (PE) and epiblast (EPI) are two
lineages derived from the inner cell mass (ICM) of the E3.5 mouse
blastocyst. They form morphologically distinct layers in the
implanting embryo by E4.5; the PE cells line the ICM and the EPI
cells cluster between the PE and the trophectoderm (TE) layers.
The PE becomes the parietal and visceral endoderm of the yolk sac
after implantation, while the EPI gives rise to the embryonic
proper and extraembryonic tissues like the amnion and umbilical
cord. Although the PE is an extraembryonic cell lineage, it plays
essential roles in body axis speciﬁcation as well as growth by
providing a nutrient supply until placenta formation (Artus and
Hadjantonakis, 2012; Yamanaka and Ralston, 2011).
In the last decade, we and others have analyzed the process of
PE/EPI lineage formation in the preimplantation mouse embryo.
Chazaud et al. (2006) showed that individual ICM cells have
mutually exclusive expression of lineage speciﬁc transcriptional
factors like Nanog and Gata6, in addition to having limited
contribution to PE or EPI lineages. Single cell gene expression
analysis of E3.5 ICM cells has conﬁrmed the early heterogeneity in
gene expression in the ICM (Guo et al., 2010; Kurimoto et al.,
2006). Furthermore live-imaging analysis using the PdgfraH2b-GFP
mouse line, speciﬁcally expressing histone H2b-GFP in PE pro-
genitors/cells, conﬁrmed the heterogeneity in the E3.5 ICM and
revealed the subsequent sorting process of the two progenitors
into morphologically distinct PE/EPI layers (Plusa et al., 2008).
Although positional bias in the ICM appears to exist, most PE/EPI
progenitors are randomly distributed in the early ICM and sort out
to their respective locations by migration and apoptosis. Once PE
progenitors are sorted out to the ICM surface facing the blastocoel,
they initiate apico-basal cell polarization to form the PE epithe-
lium (Gerbe et al., 2008). These studies conﬁrmed a model in
which morphologically distinct PE/EPI layers develop by sorting of
the two progenitors speciﬁed early in the E3.5 ICM. The question
still remaining is how heterogeneity emerges in the E3.5 ICM.
It has been shown that FGF signaling plays an essential role in
the formation of the PE lineage in the mouse embryo (Lanner and
Rossant, 2010). When genes such as Fgf4, Fgfr2 and Grb2 are
genetically deleted, mutant embryos do not form the PE lineage
(Arman et al., 1998; Chazaud et al., 2006; Cheng et al., 1998;
Feldman et al., 1995; Kang et al., 2013). Speciﬁcally, in Grb2 /
embryos, all ICM cells become Nanogþ EPI progenitors and no
Gata6þ PE progenitors are observed (Chazaud et al., 2006). The
timing of the FGF signaling requirement was analyzed by using
speciﬁc inhibitors against FGF receptors and/or their downstream
kinases like MEK/MAPK (Grabarek et al., 2012; Nichols et al., 2009;
Yamanaka et al., 2010). Interestingly, sustained inhibition is
required to force all ICM cells to become EPI cells during blastocyst
expansion from E3.5 to E4.5. Although the mutually exclusive
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expression of EPI and PE transcriptional factors is established by
E3.75, ﬁnal cell fates are not fully committed but changeable
through modulation of the FGF signaling level by E4.5 (Grabarek
et al., 2012; Yamanaka et al., 2010). Furthermore, it was shown
that a high dose of exogenous FGF4 was sufﬁcient to convert all
ICM cells to the PE fate (Yamanaka et al., 2010). In sum, these
studies suggest that modulating FGF signaling levels is necessary
and sufﬁcient for PE/EPI lineage speciﬁcation in the mouse
blastocyst (Yamanaka and Ralston, 2011).
Although the importance of FGF signaling is apparent in PE
speciﬁcation, it is still unknown how individual ICM cells differ-
entially choose to become either the PE or EPI lineage within the
small packed ICM. Fgf4mRNA is detectable from the one cell to the
blastocyst stage (Rappolee et al., 1994). At the blastocyst stage, its
expression is restricted in the ICM at E3.5 and later further
restricted to the EPI. Interestingly, the ﬁrst gene expression
difference linked with PE/EPI lineage formation is an inverse
correlation of Fgf4 to Fgfr2 expression (Guo et al., 2010), though
it is unknown how this difference emerges in the embryo.
In this study, we analyzed zygotic and maternally deleted Fgf4
heterozygous and homozygous mutant embryos to examine how
reducing Fgf4 gene dosage and/or removing maternal Fgf4 would
change the proportion of the PE/EPI progenitors in the ICM. We
found that both zygotic Fgf4 homozygous (ZFgf4 /) and mater-
nal/zygotic Fgf4 homozygous (MZFgf4 /) embryos have no PE
lineage, conﬁrming an Fgf4 requirement for PE formation. Inter-
estingly, in contrast to a recent study by Kang et al. (2013), we
observed a maternal contribution of Fgf4 in PE/EPI speciﬁcation,
although it is dispensable for later development. Addition of
exogenous FGF4 decreased the EPI proportion and increased the
PE proportion in a dose-dependent manner for all Fgf4 mutant
genotypes. These results suggest that the amount of FGF is limited
in the embryo, thus regulating PE/EPI proportions.
Materials and methods
Mice
Conditional Fgf4tm1.2Mrt mutant mice (Sun et al., 2002) were
obtained from MMRRC at UC Davis and maintained on the C57BL/6
background. Tg(Zp3-Cre)93Knw/J mice (de Vries et al., 2000) were
obtained from Jackson laboratory. The Fgf4 deletion allele was
generated from Fgf4ﬂox/ﬂox;Zp3-cre females. Zygotic Fgf4 mutant
embryos were collected from Fgf4þ / females crossed with Fgf4þ /
males. Maternal/zygotic Fgf4 deleted embryos were collected from
Fgf4ﬂox/ﬂox;Zp3-cre females crossed with Fgf4þ / males.
Embryo collection, culture and Fgf4/heparin treatment
Embryos were collected from oviducts or uteri by ﬂushing with
FHM medium (Millipore). Most E3.75 B6 blastocysts were hatched
out from the zona pellucida when ﬂushed from uteri, unlike CD1
blastocysts. Embryos were ﬁxed immediately or cultured in
microdrops (15 μL/drop) of KSOMþAA medium (Millipore) cov-
ered with mineral oil in an incubator at 37 1C, 5% CO2. For
exogenous FGF4 treatment, FGF4 (25 μg/mL stock in PBS/0.1%
BSA, R&D, #235-F4-025) was serially diluted in KSOMþAA and
1 μg/mL heparin (Sigma, H3149) and stored at 4 1C for several
rounds of experiments. E2.5 embryos were cultured in 15 μL drops
of KSOMþAAþheparin or KSOMþAAþheparinþFGF4 under
mineral oil (prepared and incubated 2 h prior). At E3.5 (þ24 h
incubation), embryos were treated with acid Tyrode's solution to
remove the zona pellucida, washed in FHM and then replaced into
the original incubating drops until E4.5 (48 h total). Embryos were
ﬁxed in 4% formaldehyde (Polyscience Inc.) for 45 min, immunos-
tained, and then genotyped by PCR.
Whole mount immunostaining
Embryos (with the zona pellucida intact where indicated) were
ﬁxed in 4% formaldehyde (Polyscience Inc.) in 1 PBS for 15–30 min
at RT, permeabilized in 0.3% TritonX-100-PBS for 10 min., washed in
0.1% Tween20–PBS (PBT) and incubated in blocking solution (PBT
with 10% FBS) for 1 h. Embryos were treated in primary antibodies
overnight in PBT with 10% FBS at 4 1C, washed in PBT, and treated
with secondary antibodies at RT for 1 hr in PBT. After washing,
embryos were mounted with Draq5 (BioStatus, DR50050) or POPO-1
(Molecular Probes, 1/1000 with 100 μg/mL RNase A). Primary anti-
bodies used are: Nanog (Cosmobio, rabbit), Cdx2 (Biogenex, mouse),
Sox17 (R&D, goat), Gata6 (R&D, goat), Oct3/4 (SantaCruz, sc-5279,
mouse), and Gata4 (SantaCruz, sc-9053, rabbit).
Confocal microscope and image analysis
The Quorum spinning disc confocal microscope (20 PlanAPO
objective) in the McGill CIAN imaging facility was used to scan
immunostained embryos with four laser lines (440, 491, 561 and
638 nm). Images were taken every 1–3 μm using the Volocity
software. Cell counting was performed manually on Volocity
software or automatically on the Imaris 7.4.2 software (using the
Surpass, Spots function to identify nuclei). Nuclear diameter was
estimated to be 6 μm for ICM cells and 6.5 μm for TE cells. We
used true background subtraction and intensity thresh-holding for
each channel with a Quality ﬁlter (the intensity at the center of the
spot in the channel the spot was detected) for channels with a
strong signal and Intensity-Sum ﬁlter (the sum of the intensities of
the voxels enclosed within the Spots) for channels with weak
signals. The double positive cells were manually identiﬁed and
counted. For one-way ANOVA, P-values were measured with the
Tukey HSD test. For Hartigan's Dip test, the package ‘diptest’ was
used in R software: http://cran.r-project.org/web/packages/dipt
est/index.html.
Embryo genotyping
Immunostained/scanned embryos were recovered individually
and genotyped as described in Stephenson et al., (2010). Brieﬂy,
using Sigma Extract-N-Amp PCR kit, each embryo was transferred
to 5.5 μL of EþTP mixture solution by mouth pipette. After 10 min
incubation at RT, it was treated at 56 1C for 30 min, 24 1C for 5 min
and 95 1C for 5 min. Then, the extracted DNAs were neutralized
with 4.4 μL of the N solution. After this, PCR was performed
following manufacturer's recommendation.
Primers used for wt Fgf4 alleles: EM26 5′-TCT GGA GAG GAA CTA
GGA ATG G-3′ and EM27 5′-GAA GAG AAG CAG GCA GAT GC-3′. For
deleted alleles: delF 5′-CTA CTG CAA CGT GGG CAT CG-3′ and delR
5′-AGC CTC CAG CTT AGT CAC CA-3′.
Results
Maternal Fgf4 contributes to PE/EPI speciﬁcation in the mouse
embryo
In our previous study, we showed that exogenous FGF4 is
sufﬁcient to convert all ICM cells to the PE lineage in wild type
embryos (Yamanaka et al., 2010). This suggested that in normal
development, FGF4 could control the PE/EPI proportion in the
embryo. To test this possibility, we reduced endogenous FGF4
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levels by using various genotypes of Fgf4 mutant embryos. We
collected freshly ﬂushed E3.75 blastocysts from Fgf4þ / intercrosses,
generating three Fgf4 genotypes: wild type (Fgf4þ /þ), zygotic
heterozygous (ZFgf4þ /) and zygotic homozygous (ZFgf4/). When
we compared the cell numbers of trophectoderm (TE) and inner cell
mass (ICM), there were no statistical differences among the three
genotypes (Fig. 2A). In wild type embryos (n¼21), EPI progenitors
expressing NANOG and PE progenitors expressing SOX17 and GATA6
were randomly distributed in the ICM at E3.75 (Fig. 1A and F). About
55% of ICM cells were NANOGþ EPI progenitors, 40% were SOX17þ
PE progenitors and 5% were double positive suggesting that these
cells were not speciﬁed at this time point (Fig. 2B). As previously
reported (Feldman et al., 1995; Kang et al., 2013), ZFgf4 / embryos
(n¼13) had no PE lineage cells while all ICM cells were NANOGþ
EPI progenitors at E3.75 (Figs. 1C and H, and 2A and B). Since there
was no reduction in the total ICM cell number, all ICM cells in
ZFgf4 / embryos were converted to become NANOGþ EPI pro-
genitors, as in Grb2mutant embryos (Fig. 2A) (Chazaud et al., 2006).
Interestingly, we did not observe a signiﬁcant reduction in PE
proportion in ZFgf4þ / embryos (n¼25, 63% NANOGþ , 35% EPIþ)
compared with wt embryos as reported in a recent study by Kang
et al. (2013) (Figs. 1B and G, and 2B and E).
Since Fgf4 is expressed maternally (Rappolee et al., 1994), we
wondered whether maternal Fgf4 expression masked the phenotype
of ZFgf4þ / embryos in our study. To test this, we generated a
maternal deletion of Fgf4 to achieve full reduction of Fgf4 in embryos,
using the conditional Fgf4 knockout mouse line (Sun et al., 2002)
with the oocyte-driven Zp3-Cre mouse line (de Vries et al., 2000). We
compared the cell numbers of TE and ICM between MFgf4þ /
(n¼13, maternal deletion only) and MZFgf4 / (n¼14, maternal
and zygotic deletion) freshly ﬂushed embryos, and no difference was
observed (Fig. 2C). Consistent with the previous study (Kang et al.,
2013), in freshly ﬂushed MZFgf4/ embryos, no SOX17þ and
GATA6þ/SOX17þ PE lineage cells were observed at E3.75, similar
to in Z Fgf4 / embryos (Fig. 1E and J). In contrast with the same
study, we observed an increase in the EPI proportion and a reduction
in the PE proportion of E3.75 ICM in MFgf4þ / embryos (13%
SOX17þ PE in MFgf4þ / versus 35% in ZFgf4þ / , ANOVA, Po0.01),
suggesting a maternal contribution of Fgf4 in PE/EPI speciﬁcation
(Figs. 1D and I, and 2D and E). Although the variability in the
proportion of Sox17þ PE progenitors between individual embryos
in each non-null genotype was moderate (Fig. 2E), it is not correlated
with the number of ICM cells (Fig. 2F).
Although both SOX17þ and GATA6þ PE progenitors were
absent in both MZFgf4/ and ZFgf4 / at E3.75, early GATA6
expression at E3.25 in all ICM cells was not affected (Fig. 1K and L),
suggesting that initial GATA6 expression is dependent on neither
maternal nor zygotic Fgf4.
Fgf4 dose-dependent regulation of the proportion
of PE/EPI progenitors
It was shown that exogenous FGF4 is sufﬁcient to convert all ICM
cells to PE lineage in a dose-dependent manner (Yamanaka et al.,
2010). However, this study did not examine how PE/EPI proportions
change during this conversion. To address this, we harvested E2.5
embryos of various Fgf4 genotypes and cultured them with exo-
genous FGF4 (0–500 ng/mL) and heparin (1 μg/mL) in-vitro for 48 h.
Although we did not ﬁnd differences in PE/EPI proportions
between wt and ZFgf4þ / freshly isolated embryos (Fig. 2E), we
observed a statistically signiﬁcant difference in the proportion of
NANOGþ cells and SOX17þ cells betweenwt and ZFgf4þ / cultured
embryos (Fig. 3A, 0 ng/mL FGF4; ANOVA Po0.05). In culture condi-
tions, the Fgf4 maternal effect appeared to be attenuated.
In both ZFgf4 / and MZFgf4/ embryos, no PE cells were
observed after culture alone (Fig. 3A and B, 0 ng/mL FGF4). However,
restoration of PE progenitors was observed in FGF4 concentrations as
low as 62.5 ng/mL, where most Z and MZ null embryos had between
10 and 30% PE (Fig. 3A–C). All other genotypes at this dose (wt,
ZFgf4þ / and MFgf4þ /) also showed an increase in PE proportions
compared to non-treated cultured embryos, correlating with geno-
type. Speciﬁcally, Z and MZ null embryos had lower PE proportions,
ZFgf4þ / and MFgf4þ / had intermediate proportions, and wt
embryos had the highest proportions (Fig. 3C). In all genotypes, the
SOX17þ PE proportion increased as the NANOGþ EPI proportion
decreased, in an FGF4 dose-dependent manner (Fig. 3A, B, and not
shown). Additionally, no double-negative ICM cells were ever
observed, suggesting that all cells were speciﬁed to either fate.
At 125 ng/mL FGF4, 30–40% of FGF treated embryos had an all-PE
phenotype regardless of genotype (Fig. 3D). Unlike at 62.5 ng/mL
FGF4, where PE proportion was linked to genotype, this was not
obvious at 125 ng/mL FGF4. Additionally, embryo-to-embryo variabil-
ity in PE proportions was high at 125 ng/mL FGF4 in all genotypes
(Fig. 3A and B).
In a cumulative distribution frequency plot (Fig. 3D), we found
the curve of ZFgf4/ embryos treated with 125 ng/mL to be
shifted to a lower PE proportion compared with other genotypes.
This suggested that many embryos in this group had a relatively
lower number of Sox17þ cells, despite 30% of the embryos
showing an all-PE phenotype. Since this distribution pattern
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Fig. 1. Blastocyst lineage marker expression in ﬂushed Fgf4 mutant embryos. (A)–(E) Projected confocal images of hatched E3.75 blastocysts immunostained for lineage-
speciﬁc transcription factors, NANOG (EPI, red), SOX17 (PE, green) and CDX2 (TE, blue). (F)–(J) Projected confocal images of hatched E3.75 blastocysts immunostained for
NANOG (EPI, red), GATA6 (PE, green) and CDX2 (TE, blue). (F′)–(J′) Projected monochromatic GATA6 images from embryos (F)–(J). Arrows, TE expression of GATA6;
arrowheads, PE expression of GATA6. K,L. Confocal sections of unhatched E3.25 blastocysts immunostained for NANOG (EPI, red), GATA6 (PE, green) and CDX2 (TE, blue). (K′)
and (L′) Projected monochromatic GATA6 images from embryos (K) and (L).
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appeared to be bimodal, we performed Hartigan's Dip test for
unimodality (Hartigen and Hartigan, 1985) and a normal prob-
ability plot analysis (not shown). The results conﬁrmed a bimodal
distribution of this ZFgf4 / group (Po0.01) suggesting that some
embryos in this group have lower sensitivity (or higher resistance)
to change PE/EPI proportions in response to exogenous FGF4.
Our results show that the increase of PE proportions in the ICM
correlates with the amount of exogenous FGF4 applied. Taken
together, we conclude that the level of FGF4 in the embryo
regulates the proportion of PE/EPI cells in the mouse embryo.
MFgf4þ / embryos can restore primitive endoderm progenitors
during implantation and develop normally
Although the PE proportion in E3.75 MFgf4þ / embryos was
reduced, live pups of MFgf4þ / were born from crosses between
Z Fgf4+/- (n=25)
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Fig. 2. PE/EPI proportions in ﬂushed E3.75 Fgf4 mutant blastocysts. (A) Cell numbers of blastocyst lineages in wild type and ZFgf4 mutants at E3.75. There was no difference
in TE and ICM cell numbers among WT, ZFgf4þ / and ZFgf4/ . “EPIþ/PEþ” are double-positive cells; there were no double-negative ICM cells. (B) PE/EPI proportions in
ZFgf4 mutants at E3.75. 54% of ICM cells in wild type and 61% ZFgf4þ / embryos were NANOGþ EPI progenitors, while 40% and 36% were SOX17þ PE progenitors,
respectively. No SOX17þ PE progenitors were observed in ZFgf4 / embryos. (C) Cell numbers of blastocyst lineages in M/MZFgf4 mutants at E3.75. There was no difference
in TE and ICM cell numbers between MFgf4þ / and MZFgf4 / . “EPIþ/PEþ” are double-positive cells; there were no double-negative ICM cells. (D) PE/EPI proportions in
M/MZFgf4 mutants at E3.75. 77% of ICM cells in MFgf4þ / embryos were NANOGþ EPI progenitors while 15% were SOX17þ PE progenitors. (E) Box and whisker plot of the
proportion of SOX17þ cells (double positive cells are excluded) in E3.75 ICMs. Circle, outlier. Diamond, mean. Line, median. No signiﬁcant difference is found betweenwt and
ZFgf4þ / or ZFgf4/ and MZFgf4/ . Statistically signiﬁcant differences are observed between all other groups (ANOVA, Po0.01). (F) Dot-plot of the proportion of SOX17þ
cells and total ICM cell numbers. (A)–(F) EPI¼NANOGþ , PE¼SOX17þ , TE¼CDX2þ , and EPIþPEþ¼NANOGþ SOX17þ .
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Fgf4ﬂox/ﬂox;Zp3-Cre females and ZFgf4þ / males or wild type males.
The litter size of crosses between the Fgf4ﬂox/ﬂox;Zp3-Cre females
and wild type males (8.573.87 pups/litter, n¼4) was not sig-
niﬁcantly different than in wild type crosses (6.870.83 pups/litter,
n¼5, t-test P¼0.45). This suggests that MFgf4þ / embryos devel-
oped normally despite having a smaller number of PE progenitors
at E3.75.
Since previous analyses from us and others showed a time
delay of lineage commitment after E3.75 PE/EPI speciﬁcation
(Yamanaka et al., 2010; Grabarek et al., 2012) we examined if
freshly ﬂushed MFgf4þ / embryos restored normal PE cell num-
bers by E4.5. These embryos (n¼4) were morphologically indis-
tinguishable from wt and ZFgf4þ / embryos (Fig. 4A–C), however
we still observed a reduction of PE cells inMFgf4þ / E4.5 embryos
(Fig. 4D). Probably, in MFgf4þ / embryos, a steady increase in
FGF4 levels still allows recovery of PE numbers by their ﬁnal
determination at E4.5 or there may be continued FGF4-
independent proliferation of PE cells after PE speciﬁcation, as seen
in PDGFRa null mutants (Artus et al., 2010).
Discussion
We observed that FGF4 treated embryos progressively
increased PE proportions in an FGF4 dose dependent manner,
regardless of genotype. This suggests that FGF4 is an essential
factor for PE formation and regulates PE/EPI proportions in the
mouse embryo. Consistent with the recent study by Kang et al., no
PE cells formed in the absence of endogenous FGF4, as in ZFgf4 /
and MZFgf4 / embryos. Speciﬁcally, no SOX17 and GATA4
expression was observed and all ICM cells maintained a high level
of NANOG expression despite early activation of GATA6 expression.
However, there are some clear differences between the two
studies. First, we observed no difference in PE proportions
between wt and ZFgf4þ / embryos. Second, we observed a
signiﬁcant reduction of PE proportions in MFgf4þ / , suggesting
maternal contribution of Fgf4 in PE speciﬁcation. We think that
these two differences are potentially due to the mouse strains used
in the two studies. Our study was carried out in the B6 genetic
background, compared to the CD1 outbred background used in
Kang et. al. It is possible that a higher maternal contribution of Fgf4
in the B6 mouse strain masked the difference between wt and
ZFgf4þ / embryos in our study. Interestingly, we were able to
observe a difference in PE proportions between wt and ZFgf4þ /
embryos, but only when the embryos were cultured in-vitro. We
speculate that the in-vitro culture conditions, which are not
identical to the uterine environment in oxygen and nutrients, affect
the metabolic state of the embryo. This difference in metabolic state
could potentially inﬂuence and attenuate the maternal Fgf4 contribu-
tion in cultured embryos. Although we showed that maternal FGF4
contributes to PE/EPI proportions, we ﬁnd it is dispensable for
development. MFgf4þ / embryos can implant and develop normally
despite having smaller PE numbers at E3.75 and E4.5. Without
maternal FGF4, the initial speciﬁcation process was strongly skewed
to a NANOGþ EPI lineage. As zygotic FGF4 expression increases with
time, this skewed balance of PE/EPI proportions seems to be compen-
sated by re-speciﬁcation of NANOGþ EPI progenitors, by proliferation
in the PE lineage or both.
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Po0.01, wt vs. Zþ / or Z / , Mþ / vs. M/ . Numbers in parentheses indicate the number of embryos analyzed. (C) and (D) Cumulative distribution frequency (CDF) plots
of the proportion of SOX17þ cells in cultured Fgf4 mutant embryos at two FGF4 doses.
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A third difference between our study and Kang et al., is that when
Z and MZ null embryos were exposed to exogenous FGF4 or FGF2
(data not shown), we observed that the PE/EPI proportion progres-
sively changed from 100% EPI progenitors to 100% PE progenitors in
an FGF4 dose-dependent manner. Conversely, Kang et al. observed
that Fgf4 null embryos only showed a binary, all-or-none response to
exogenous FGF treatment. It is not clear what caused this difference,
but we speculate that this could also be linked to the mouse strains
used. Other possibilities include the smaller sample size used (13 Fgf4
null embryos for four dose points versus 129 Fgf4 null embryos for
ﬁve dose points in our study) and the difference in FGF ligands
mainly used in the two studies (FGF2 versus FGF4). Future studies
aimed at addressing early mouse strain differences would be
important to understand these apparent discrepancies and would
bring new insight into mouse preimplantation development.
The ﬁrst gene expression difference linked with PE/EPI speci-
ﬁcation in ICM cells is an inverse correlation in expression of the
receptor–ligand pair Fgfr2/Fgf4 (Guo et al., 2010). This inverse
correlation is apparently established by a decrease in Fgfr2 (highly
expressed at the 16-cell stage) and an increase of Fgf4 (low at the
16-cell stage) within a subpopulation of 32-cell ICM cells that have
relatively uniform expression of Nanog and Gata6 (Guo et al.,
2010). It is unknown whether this mRNA expression difference is
directly reﬂected in protein levels, but if it is, gradual variability in
Fgf4/Fgfr2 inverse ratios could create variability in FGF responsive-
ness to the same FGF dose in the packed ICM (Fig. 5, top left). Thus,
the combination of a certain amount of FGF and a level of receptor
expression could control the PE/EPI proportion. Interestingly, we
observed a bimodal distribution of PE proportions in ZFgf4 /
embryos treated with 125 ng/mL of FGF4, despite the frequency of
the all-PE ICM phenotype being similar to other genotypes. This
bimodal distribution could reﬂect the existence of different FGF
responsiveness in the ICM, where a subpopulation of ICM cells,
likely EPI progenitors, have relatively higher resistance to become
PE. The idea that the ICM could have two populations with high
and low FGF sensitivity is consistent with Grabarek et al. (2012)
where EPI progenitors had more restricted potential and were less
sensitive to exogenous FGF than the more plastic PE progenitors.
In our study, the bimodal distribution seen in ZFgf4 / was not
observed in MZFgf4 / , suggesting that maternal Fgf4 might be
required to create the initial different FGF responsiveness in
the ICM.
However, is early variability in FGF responsiveness necessary in
the ICM to generate the PE/EPI lineages? It is worth to note that
there is no direct evidence (such as restricted phospho-MAPK and
phospho-FGFR staining in a subset of ICM cells) to support
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Fig. 4. Morphology of freshly dissected e4.5 MFgf4þ / embryos is indistinguish-
able from wild type and ZFgf4þ / embryos. (A)–(C) Confocal projections of E4.5
embryos immunostained for NANOG (red, EPI), SOX17 (green, PE) and CDX2 (blue,
TE). (D) PE/EPI cell numbers at E4.5. The number of PE cells inMFgf4þ / (n¼4) was
smaller than in wild type and ZFgf4þ / (ANOVA Po0.05).
Heterogeneity in FGF responsiveness  
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Fig. 5. A model of PE/EPI speciﬁcation in the mouse embryo. Top left: ICM cells could have preexisting heterogeneity based on divisional history or position in the ICM.
Although all ICM cells can respond to FGF, this responsiveness might be varied. A fraction of ICM cells may be biased to either PE or EPI lineage due to high or low Fgfr
expression. Others are less or not biased and stochastically respond to FGF. Bottom left: heterogeneity is established by weak activation of FGF signaling in ICM cells and this
evokes stochastic ﬂuctuation of gene expression in ICM cells (as seen in ES cells). Other mechanisms should be involved to stabilize this ﬂuctuation and adjust the PE/EPI
proportion in an FGF dose dependent manner. The inverse correlation of Fgf4/Fgfr2 expression might be a part of this scheme. These two models are not exclusive but could
co-exist in the embryo.
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different FGF responsiveness in the ICM, although this could be
due to low and/or transient activation (Frankenberg et al., 2011,
unpublished data). It is known that there is stochastic variability in
gene expression in mouse ES cells (Wray et al., 2010). Interestingly,
several ES cell genes ﬂuctuate their expression in an FGF signaling
dependent manner (Lanner et al., 2010; Wray et al., 2010),
although this is not due to a difference in FGF responsiveness of
individual cells, as phospho-MAPK is uniformly activated (Kunath
et al., 2007). As in mouse ES cells, the FGF signaling cascade might
be weakly activated in all early ICM cells (Fig. 5, bottom left).
A stochastic response in gene expression could initiate the
expression of different sets of genes linked with lineage speciﬁca-
tion. FGF dose could control the frequency of gene ﬂuctuation in a
cell, therefore regulating the PE/EPI proportion. Other mechanisms
are probably also involved to stabilize initial stochastic differences
in order to adjust the balance of PE/EPI proportions. Inverse
expression of Fgf4/Fgfr2 could be a part of this scheme.
These models are not exclusive and could co-exist in the
embryo. It was shown that a subpopulation of ICM cells is biased
to be EPI or PE based on their position in the ICM or divisional
history (Morris et al., 2010; Plusa et al., 2008). On the other hand,
our data showed that many ICM cells are plastic to change their
fate in a FGF dose dependent manner. It will be interesting to
address whether the inverse expression of Fgf4/Fgfr2 is a cause or a
consequence of generation of these two populations. Forced uni-
form/ectopic expression of FGF receptors could answer this ques-
tion in the future.
How much is this process evolutionarily conserved? Recent
studies on human and bovine embryos show differences in
preimplantation development compared to mice (Kuijk et al.,
2012; Roode et al., 2012). Interestingly, the complete block of PE
formation in mice caused by inhibition of the MAPK/MEK cascade
has no effect on human embryo development and only a partial
effect on bovine embryos. This raises a couple of important
questions. First, what does regulate PE/EPI speciﬁcation in these
species? Although the existence of another RTK signaling pathway
inﬂuencing PE formation in the mouse embryo has been suggested
(Frankenberg et al., 2011), it seems to be MAPK/MEK inhibitor
sensitive and therefore unlikely to be the mechanism used in these
other species. Second, as human and bovine do not use FGF-
dependent regulation, do these species exhibit the high develop-
mental plasticity observed in mouse embryos? Interestingly,
although all mammals appear to form a blastocyst and use the
same set of lineage speciﬁc transcriptional factors, their mechan-
isms to specify cell lineages might be diversiﬁed.
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